Cited by 200Cannabis and Cannabinoid ResearchPain Mechanisms and TreatmentsFatty Acid Research and Health

The DOI matches its Crossref record, with a small difference in title or year; 91 of the 91 references it cites were found in a registry or an index.

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: Potential use in companion animals

Re, G., Barbero, R., Miolo, A., Di Marzo, V.·2007·The Veterinary Journal

DOI 10.1016/j.tvjl.2005.10.003

Open this paper in CoChat — free account

Abstract

Endocannabinoids have analgesic/anti-inflammatory properties. The biology of endocannabinoids, their receptors, signalling mechanisms and role in the regulation of physiological processes have been extensively reviewed. This review focuses on the role of palmitoylethanolamide (PEA), an endogenous fatty acid amide analogue of the endocannabinoid anandamide, in tissue protective mechanisms. PEA was first identified almost five decades ago in lipid extracts of various natural products, and its anti-inflammatory and antinociceptive effects were established later. Evidence exists that PEA is synthesised during inflammation and tissue damage and a number of beneficial effects, including the relief of inflammation and pruritus, have been shown to be useful in the control of neurogenic and neuropathic pain. The postulated hypotheses as to the mode of action of PEA include a possible local autacoid-like mediator activity regulating mast-cell activity and putative activation of cannabinoids and vanilloid TRPV1 receptors via "entourage" effects. The large number of scientific investigations into the effects of PEA and PEA-related compounds has given rise to new therapeutic opportunities. In spite of the multitude of therapies currently employed to control inflammation, pain, pruritus and tissue damage, the possibility of using a natural compound, such as PEA to manipulate endogenous protective mechanisms may be considered a beneficial novel therapeutic strategy in veterinary medicine.

Integrity signals

Registry

Crossref · 10.1016/j.tvjl.2005.10.003

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

THIS ARTICLE HAS BEEN RETRACTED Activation of capsaicin‐sensitive primary sensory neurones induces anandamide production and release
Ahluwalia, J., Yaqoob, M., Urbán, L., Bevan, S., & Nagy, I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01550.x · Cited by 82
Retracted
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
THE MANAGEMENT OF PAIN
Bonica, J. J. (1954) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195405000-00015 · Cited by 1,467
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,069
Pathobiology of neuropathic pain
Zimmermann, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01303-6 · Cited by 935
Nerve growth factor: from neurotrophin to neurokine
Levi‐Montalcini, R., Skaper, S. D., Toso, R. D., Petrelli, L., & Leon, A. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10058-8 · Cited by 686
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity
Ben‐Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M. H., Vogel, Z., Bisogno, T., PETROCELLIS, L. D., Marzo, V. D., & Mechoulam, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00392-6 · Cited by 650
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3376 · Cited by 632
Anandamide and vanilloid TRPV1 receptors
Ross, R. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705467 · Cited by 603
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 581
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
Richardson, J. D., Kilo, S., & Hargreaves, K. (1998) · Pain · doi:10.1016/s0304-3959(97)00213-3 · Cited by 501
Activation of CB 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491
Pain modulation by release of the endogenous cannabinoid anandamide
Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 486
Endocannabinoids
Mechoulam, R., Fride, E., & Marzo, V. D. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 447
Itch: scratching more than the surface
Twycross, R. (2003) · QJM · doi:10.1093/qjmed/hcg002 · Cited by 412
Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures
Ständer, S., Moormann, C., Schumacher, M. A., Buddenkotte, J., Artuc, M., Shpacovitch, V. M., Brzoska, T., Lippert, U., Henz, B. M., Luger, T. A., et al. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.0178.x · Cited by 410
CB2 cannabinoid receptor-mediated peripheral antinociception
Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391
Endovanilloids
van der Stelt, M., & Marzo, V. D. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04081.x · Cited by 388
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes
Bisogno, T., Maurelli, S., Melck, D. J., PETROCELLIS, L. D., & Marzo, V. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3315 · Cited by 368
The clinical picture of neuropathic pain
Jensen, T. S., Gottrup, H., Sindrup, S. H., & Bach, F. W. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01302-4 · Cited by 355
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
Jaggar, S., Hasnie, F. S., Sellaturay, S., & Rice, A. S. C. (1998) · Pain · doi:10.1016/s0304-3959(98)00041-4 · Cited by 352
The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain
Walker, K. M., Urbán, L., Medhurst, S. J., Patel, S., Panesar, M., Fox, A. J., & McIntyre, P. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042010 · Cited by 346
N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation
Mazzari, S., Canella, R., Petrelli, L., Marcolongo, G., & Leon, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00015-5 · Cited by 334
Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP
Cadas, H., Gaillet, S., Beltramo, M., Venance, L., & Piomelli, D. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03934.1996 · Cited by 318
Cannabinoid receptors and the regulation of immune response
Berdyshev, E. V. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00195-x · Cited by 285
Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor
Sheskin, T., Hanuš, L., Slager, J., Vogel, Z., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960752x · Cited by 274
Endovanilloid signaling in pain
Marzo, V. D. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00340-9 · Cited by 272
The Palmitoylethanolamide and Oleamide Enigmas: Are These Two Fatty Acid Amides Cannabimimetic?
Lambert, D. M., & Marzo, V. D. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401153732 · Cited by 244
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
Calignano, A., Rana, G. L., & Piomelli, D. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00988-8 · Cited by 243
Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors
Quartilho, A., Mata, H. P., Ibrahim, M. M., Vanderah, T. W., Porreca, F., Makriyannis, A., & Malan, T. P. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00031 · Cited by 243
Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor
Liu, J., Bátkai, S., Pacher, P., Harvey-White, J. D., Wagner, J. A., Cravatt, B. F., Gao, B., & Kunos, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306062200 · Cited by 234
Palmitoylethanolamide Increases after Focal Cerebral Ischemia and Potentiates Microglial Cell Motility
Franklin, A., Parmentier‐Batteur, S., Walter, L. M., Greenberg, D. A., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07767.2003 · Cited by 232
Are opioids effective in relieving neuropathic pain?
Dellemijn, P. L. I. (1999) · Pain · doi:10.1016/s0304-3959(98)00256-5 · Cited by 224
Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells
Zuo, Y., Perkins, N. M., Tracey, D. J., & Geczy, C. L. (2003) · Pain · doi:10.1016/s0304-3959(03)00261-6 · Cited by 221
Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration
Hansen, H. H., Schmid, P. C., Bittigau, P., Lastres‐Becker, I., Berrendero, F., Manzanares, J., Ikonomidou, C., Schmid, H. H. O., Fernández‐Ruiz, J. J., & Hansen, H. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00542.x · Cited by 215
Physiology of Pain
Lamont, L. A., Tranquilli, W. J., & Grimm, K. A. (2000) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/s0195-5616(08)70003-2 · Cited by 212
A proposed autacoid mechanism controlling mastocyte behaviour
Aloe, L., Leon, A., & Levi‐Montalcini, R. (1993) · Inflammation Research · doi:10.1007/bf01972748 · Cited by 209
What is the physiological function of mast cells?
Maurer, M., Theoharides, T. C., Granstein, R. D., Bischoff, S. C., Bienenstock, J., Henz, B. M., Kovanen, P. T., Piliponsky, A. M., Kambe, N., Vliagoftis, H., et al. (2003) · Experimental Dermatology · doi:10.1111/j.0906-6705.2003.0109a.x · Cited by 208
Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors
PETROCELLIS, L. D., Davis, J. B., & Marzo, V. D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02934-9 · Cited by 204
Topical capsaicin—a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study
Lysy, J., Sistiery-Ittah, M., Israelit, Y., Shmueli, A., Strauss‐Liviatan, N., Mindrul, V., Keret, D., & Goldin, E. (2003) · Gut · doi:10.1136/gut.52.9.1323 · Cited by 198
Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells
Marzo, V. D., PETROCELLIS, L. D., Sepe, N., & BUONO, A. (1996) · Biochemical Journal · doi:10.1042/bj3160977 · Cited by 195
Characterization of Functional Vanilloid Receptors Expressed by Mast Cells
Bı́ró, T., Maurer, M., Modarres, S., Lewin, N. E., Brodie, C., Ács, G., Acs, P. I., Paus, R., & Blumberg, P. M. (1998) · Blood · doi:10.1182/blood.v91.4.1332 · Cited by 192
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat
Conti, S., Costa, B., Colleoni, M., Parolaro, D., & Giagnoni, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704466 · Cited by 189
Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
Rice, A. S. C., Farquhar-Smith, W. P., & Nagy, I. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0362 · Cited by 183
Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia
Richardson, J. D., Aanonsen, L., & Hargreaves, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00451.1998 · Cited by 182
Anandamide regulates neuropeptide release from capsaicin‐sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro
Ahluwalia, J., Urbán, L., Bevan, S., & Nagy, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02703.x · Cited by 181
Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation
Nackley, A. G., Makriyannis, A., & Hohmann, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00126-x · Cited by 179
Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells
Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 168
Mast cells: Beyond IgE
Rosenwasser, L. J., & Boyce, J. A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.60 · Cited by 166
Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives
Hohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 161
Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin
Dvorak, M., Watkinson, A., McGlone, F. P., & Rukwied, R. (2003) · Inflammation Research · doi:10.1007/s00011-003-1162-z · Cited by 156
Update of the NGF saga
Levi‐Montalcini, R., Toso, R. D., della Valle, M. F., Skaper, S. D., & Leon, A. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00007-o · Cited by 153
SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
Richardson, J. D., Aanonsen, L., & Hargreaves, K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00952-1 · Cited by 149
Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies
Darmani, N. A., Izzo, A. A., Degenhardt, B. F., Valenti, M., Scaglione, G., Capasso, R., Sorrentini, I., & Marzo, V. D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.001 · Cited by 144
Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo‐oxygenase systems
Costa, B., Conti, S., Giagnoni, G., & Colleoni, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704900 · Cited by 142
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
Samson, M.-T., Small-Howard, A. L., Shimoda, L. M. N., Koblan‐Huberson, M., Stokes, A. J., & Turner, H. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4953 · Cited by 139
‘Entourage’ effects of N‐acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide‐induced vanilloid receptor activation and upon anandamide metabolism
Smart, D., Jonsson, K., Vandevoorde, S., Lambert, D. M., & Fowler, C. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704732 · Cited by 139
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB1 and CB2-like receptors
Farquhar-Smith, P. W., Jaggar, S., & Rice, A. S. C. (2002) · Pain · doi:10.1016/s0304-3959(01)00419-5 · Cited by 132
Hyperalgesia due to nerve damage: role of nerve growth factor
Theodosiou, M., Rush, A. R., Zhou, F. X., Hu, D., Walker, S. J., & Tracey, J. D. (1999) · Pain · doi:10.1016/s0304-3959(99)00018-4 · Cited by 130
Increased Expression of Vanilloid Receptor 1 on Myelinated Primary Afferent Neurons Contributes to the Antihyperalgesic Effect of Capsaicin Cream in Diabetic Neuropathic Pain in Mice
Rashid, M. H., Inoue, M., Bakoshi, S., & Ueda, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050948 · Cited by 123
Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide
Ross, R. A., Brockie, H. C., & Pertwee, R. G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00437-4 · Cited by 119
A neural pathway for itch
Schmelz, M. (2001) · Nature Neuroscience · doi:10.1038/82956 · Cited by 113
Endocannabinoids and related fatty acid derivatives in pain modulation
Walker, J. M., Krey, J. F., Chu, C. J., & Huang, S. M. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00152-4 · Cited by 113
Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors
Lambert, D. M., DiPaolo, F. G., Sonveaux, P., Kanyonyo, M. R., Govaerts, S. J., Hermans, E., Bueb, J., Delzenne, N. M., & Tschirhart, E. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00132-8 · Cited by 113
Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system
Pestonjamasp, V. K., & BURSTEIN, S. H. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00110-6 · Cited by 110
Cannabinoid agonists attenuate capsaicin-induced responses in human skin
Rukwied, R., Watkinson, A., McGlone, F. P., & Dvorak, M. M. (2003) · Pain · doi:10.1016/s0304-3959(02)00401-3 · Cited by 108
Molecular architecture of the vanilloid receptor
Ferrer-Montiel, A. V., Garcı́a-Martı́nez, C., Morenilla‐Palao, C., García‐Sanz, N., Fernández-Carvajal, A. M., Fernandez-Ballester, G. J., & Planells‐Cases, R. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04083.x · Cited by 102
Inhibition of pain responses by activation of CB2 cannabinoid receptors
Malan, T. P., Ibrahim, M. M., Vanderah, T. W., Makriyannis, A., & Porreca, F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00155-x · Cited by 99
Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat
Helyes, Z., Németh, J., Thán, M., Bölcskei, K., Pintér, E., & Szolcsányi, J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00651-9 · Cited by 85
Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells
Small-Howard, A. L., Shimoda, L. M. N., Adra, C. N., & Turner, H. C. (2005) · Biochemical Journal · doi:10.1042/bj20041682 · Cited by 77
A Novel Neuroimmune Mechanism in Cannabinoid-mediated Attenuation of Nerve Growth Factor–induced Hyperalgesia
Farquhar-Smith, W. P., & Rice, A. S. C. (2003) · Anesthesiology · doi:10.1097/00000542-200312000-00024 · Cited by 75
Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones
Ahluwalia, J., Urbán, L., Bevan, S., Capogna, M., & Nagy, I. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00601-7 · Cited by 75
Human mast cells take up and hydrolyze anandamide under the control of 5‐lipoxygenase and do not express cannabinoid receptors
Maccarrone, M., Fiorucci, L., Erba, F., Bari, M., Finazzi‐Agrò, A., & Ascoli, F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01223-0 · Cited by 75
Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats
Sokal, D. M., Elmes, S. J. R., Kendall, D. A., & Chapman, V. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00195-3 · Cited by 67
Cannabimimetic fatty acid derivatives in cancer and inflammation
Marzo, V. D., Melck, D. J., PETROCELLIS, L. D., & Bisogno, T. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00054-x · Cited by 66
Cannabinoid modulation of peripheral autonomic and sensory neurotransmission
Ralevic, V. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01813-2 · Cited by 60
Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study
Scarampella, F., Abramo, F., & Noli, C. (2001) · Veterinary Dermatology · doi:10.1046/j.1365-3164.2001.00214.x · Cited by 59
Topical capsaicin therapy in humans with hemodialysis-related pruritus
Weißhaar, E., Dunker, N., & Gollnick, H. P. M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00511-1 · Cited by 56
Endocannabinoid Degradation, Endotoxic Shock and Inflammation
Maccarrone, M., Bari, M., Battista, N., & Finazzi‐Agrò, A. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344878 · Cited by 48
The Pharmacology of Cannabis Indica
Dixon, W. E. (1899) · BMJ · doi:10.1136/bmj.2.2030.1517 · Cited by 47
The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis
Gingold, A. R., & Bergasa, N. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00668-4 · Cited by 43
Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1)
Phelps, P. T., Anthes, J. C., & Correll, C. C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.045 · Cited by 36
Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells
Lau, H. Y. A., & Chow, S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01430-4 · Cited by 34
The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double‐blinded, placebo‐controlled, cross‐over clinical trial
Marsella, R., Nicklin, C. F., & Melloy, C. (2002) · Veterinary Dermatology · doi:10.1046/j.1365-3164.2002.00292.x · Cited by 32
VOMITING IN GRAVES'S DISEASE AND ITS TREATMENT
Nixon, J. A. (1911) · BMJ · doi:10.1136/bmj.2.2655.1354 · Cited by 21
Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex
Steffens, M., Feuerstein, T. J., Velthoven, V. V., Schnierle, P., & Knörle, R. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0817-1 · Cited by 19
FC‐59 Mast cell morphometry of cutaneous wounds treated with an autacoid gel: a placebo‐ controlled study
Abramo, F., Salluzzi, D., Leotta, R. G., Noli, C., Auxilia, S. T., Mantis, P., & Lloyd, D. H. (2004) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2004.411_59.x · Cited by 5
Valutazione morfometrica del processo di cicatrizzazione in ferite aperte nel cane
Abramo, F., Leotta, R., Ropars, J., Noli, C., Auxilia, S. T., Mantis, P., & Lloyd, D. (2004) · CINECA IRIS Institutial research information system (University of Pisa) · Cited by 1

Research works printed but not linked: 1

Jack, 1996, Aliamides: a new approach to the treatment of inflammation, Drug News and Perspectives, 9, 93

Sorted by citations

The neurobiology of itch
Ikoma, A., Steinhoff, M. S., Ständer, S., Yosipovitch, G., & Schmelz, M. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1950 · Cited by 984
Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications
Carta, G., Murru, E., Banni, S., & Manca, C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00902 · Cited by 862
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505
Anti-Inflammatory, Antioxidant and Crystallographic Studies of N-Palmitoyl-ethanol Amine (PEA) Derivatives
Saturnino, C., Popolo, A., Ramunno, A., Adesso, S., Pecoraro, M., Plutino, M. R., Rizzato, S., Albinati, A., Marzocco, S., Sala, M., et al. (2017) · Molecules · doi:10.3390/molecules22040616 · Cited by 451
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Iannotti, F. A., Marzo, V. D., & Petrosino, S. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.02.002 · Cited by 373

See all 200

Authors: Re, G., Barbero, R., Miolo, A., & Di Marzo, V.
Affiliations: University of Turin (IT)
Corresponding author: Re, G.
ORCID: Re, G.
Barbero, R.
Venue: The Veterinary Journal
Publisher: Elsevier BV
Published: 2007-01
Volume: 173
Issue: 1
Pages: 21-30
ISSN: 1090-0233 (ISSN-L)
DOI: 10.1016/j.tvjl.2005.10.003
OpenAlex: W2037219926
Cited by: 199
References: 91
Citations by year: 2026: 2 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 13 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 17
FWCI: 0.86
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Veterinary Journal (publishedVersion)
PubMed (publishedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Keywords: palmitoylethanolamide, endocannabinoids, anandamide, anti-inflammatory activity, analgesia, neuropathic pain, pruritus, mast cells, TRPV1, entourage effect, fatty acid amides, tissue damage, companion animals
MeSH terms: Amides, Analgesics, Animals, Cannabinoids, Ethanolamines, Inflammation, Pain, Palmitic Acids, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: Potential use in companion animals

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks